Abstract: . . .  approach to blood pressure control. Fam Med 2002;34:508-13. 40. Snow V, Weiss KB, Mottur-Pilson C. The evidence base for tight blood pressure control in the management of type 2 diabetes mellitus. Ann Intern Med 2003;138:587-92. 41. Vijan S, Hayward RA. Treatment of hypertension in type 2 diabetes mellitus: blood pressure goals, choice of agents, and setting priorities in diabetes care. Ann Intern Med 2003;138:593-602.  . . .
. . .  H, Dahlof B et al. Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE) : a randomised trial against atenolol. Lancet 2002;359:1004-10. 38. Waeber B. Le contrle de la pression artrielle chez le malade risque cardiovasculaire lev. Med Hyg 2002;60(2397):1247-9. 39. Maue SK, Rivo ML, Weiss B, Farrelly EW, Brower-Stenger S. Effect of a primary care physician-focused, population-based approach to blood pressure control. Fam Med 2002;34:508-13.  . . .
. . .  B, Guilhot J, Salanave B, Fender P, Allemand H. Hypertension artrielle : quels traitements ? quels rsultats ? ADSP Actualits et Dos- siers en Sant Publique 2000;32:8-11. 16. Fender P, Guilhot J, Tilly B, Salanave B, Allemand H. Le traitement de l hypertension artrielle svre : cot de la prescription et conformit aux recommandations de lANAES. Therapie 2001;56(2):111-8. 17. Olivarius NF, Beck-Nielsen H, Andreasen AH, Horder M, Pedersen PA. Randomised controlled trial of structured personal care of type 2 dia- betes mellitus. BMJ 2001;323:970-5. . . .
. . .  Publique 2001;49:239-48. 23. Durack L, Gagnayre R, Bruckert E. Dvelopper lducation thrapeu- tique des patients risque cardiovasculaire. Sang Thromb Vaiss 2000;12(5):273-8. 24. Amouyel P, Deverly A. Risque cardiovasculaire global : dfinition, stratgies dvaluation de prise en charge. Therapie 2000 ;55 : 533-9. 25. Ornish D, Scherwitz LW, Billings JH et al. Intensive lifestyle changes for reversal of coronary heart disease. JAMA 1998 ;280 : 2001-7. 26. Ebrahim S, Davey, Smith G. Multiple risk factor interventions for primary prevention . . .
. . .  2001;49:239-48. 23. Durack L, Gagnayre R, Bruckert E. Dvelopper lducation thrapeu- tique des patients risque cardiovasculaire. Sang Thromb Vaiss 2000;12(5):273-8. 24. Amouyel P, Deverly A. Risque cardiovasculaire global : dfinition, stratgies dvaluation de prise en charge. Therapie 2000 ;55 : 533-9. 25. Ornish D, Scherwitz LW, Billings JH et al. Intensive lifestyle changes for reversal of coronary heart disease. JAMA 1998 ;280 : 2001-7. 26. Ebrahim S, Davey, Smith G. Multiple risk factor interventions for primary prevention of coronary . . .
--3000,5,300,3239,45362